Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial
2016-01-01 Lorusso, D; Scambia, G; Pignata, S; Sorio, R; Amadio, G; Lepori, S; Mosconi, A; Pisano, C; Mangili, G; Maltese, G; Sabbatini, R; Artioli, G; Gamucci, T; Di Napoli, M; Capoluongo, E; Ludovini, V; Raspagliesi, F; Ferrandina, G
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial
2023-01-01 Monk, Bradley J; Tewari, Krishnansu S; Dubot, Coraline; Caceres, M Valeria; Hasegawa, Kosei; Shapira-Frommer, Ronnie; Salman, Pamela; Yañez, Eduardo; Gümüş, Mahmut; Hurtado de Mendoza, Mivael Olivera; Samouëlian, Vanessa; Castonguay, Vincent; Arkhipov, Alexander; Tekin, Cumhur; Li, Kan; Martin Nguyen, Allison; Monberg, Matthew J; Colombo, Nicoletta; Lorusso, Domenica
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)
2018-01-01 Roncolato, Ft; Berton-Rigaud, D; O'Connell, R; Lanceley, A; Sehouli, J; Buizen, L; Okamoto, A; Aotani, E; Lorusso, D; Donnellan, P; Oza, A; Avall-Lundqvist, E; Berek, J; Hilpert, F; Ledermann, Ja; Kaminsky, Mc; Stockler, Mr; King, Mt; Friedlander, M.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials
2019-01-01 Daniele, G; Arenare, L; Scambia, G; Pisano, C; Sorio, R; Breda, E; De Placido, S; Savarese, A; Ferrandina, G; Raspagliesi, F; Panici, Pb; Ferro, A; Rimanti, A; Cormio, G; Lorusso, D; Cecere, Sc; Scalone, S; Marsico, Va; Cardalesi, C; Cognetti, F; Salutari, V; Attademo, L; Guizzaro, L; Schettino, C; Piccirillo, Mc; Perrone, F; Gallo, C; Pignata, S.
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study
2008-01-01 Adamo, V.; Lorusso, V.; Rossello, R.; Adamo, B.; Ferraro, G.; Lorusso, D; Condemi, G.; Priolo, D.; Di Lullo, L.; Paglia, A.; Pisconti, S.; Scambia, G.; Ferrandina, G.
Carboplatin-Paclitaxel Versus Cisplatin-Ifosfamide in the Treatment of Uterine Carcinosarcoma A Retrospective Cohort Study
2014-01-01 Lorusso, D; Martinelli, F; Mancini, M; Sarno, I; Ditto, A; Raspagliesi, F
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study
2017-01-01 Bogani, G; Matteucci, L; Tamberi, S; Arcangeli, V; Ditto, A; Maltese, G; Signorelli, M; Martinelli, F; Chiappa, V; Leone Roberti Maggiore, U; Perotto, S; Scaffa, C; Comerci, G; Stefanetti, M; Raspagliesi, F; Lorusso, D
Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer
2002-01-01 D'Agostino, G; Ferrandina, G; Garganese, G; Salerno, Mg; Lorusso, D; Farnetano, Mg; Mancuso, S; Scambia, G
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
2014-01-01 Pignata, S; Scambia, G; Katsaros, D; Gallo, C; Pujade-Lauraine, E; De Placido, S; Bologna, A; Weber, B; Raspagliesi, F; Panici, Pb; Cormio, G; Sorio, R; Cavazzini, Mg; Ferrandina, G; Breda, E; Murgia, V; Sacco, C; Cinieri, S; Salutari, V; Ricci, C; Pisano, C; Greggi, S; Lauria, R; Lorusso, D; Marchetti, C; Selvaggi, L; Signoriello, S; Piccirillo, Mc; Di Maio, M; Perrone, F; Martinelli, F; Multicentre Italian Trials in Ovarian cancer, (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein, (GINECO); Mario Negri Gynecologic Oncology, (MaNGO); European Network of Gynaecological Oncological Trial Groups, (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG), Investigators
Emerging drugs for ovarian cancer
2010-01-01 Lorusso, D; Pietragalla, Antonella; Mainenti, Sara; Di Legge, Alessia; Amadio, Giulia; Scambia, Giovanni
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer
2020-01-01 Lorusso, D; Ceni, V; Muratore, M; Salutari, V; Nero, C; Pietragalla, A; Ciccarone, F; Carbone, V; Daniele, G; Scambia, G; Lorusso, D; Ceni, V; Muratore, M; Salutari, V; Nero, C; Pietragalla, A; Ciccarone, F; Carbone, V; Daniele, G; Scambia, G
Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors
2014-01-01 Brown, J; Friedlander, M; Backes, Fj; Harter, P; O'Connor, Dm; Rouge, Td; Lorusso, D; Maenpaa, J; Kim, Jw; Tenney, Me; Seckl, Mj
Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety
2019-01-01 Kristeleit, Rs; Oaknin, A; Ray-Coquard, I; Leary, A; Balmaña, J; Drew, Y; Oza, Am; Shapira-Frommer, R; Domchek, Sm; Cameron, T; Maloney, L; Goble, S; Lorusso, D; Ledermann, Ja; Mcneish, Ia.
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
2007-01-01 Ferrandina, G.; Ludovisi, M.; De Vincenzo, R.; Salutari, V.; Lorusso, D; Colangelo, M.; Prantera, T.; Valerio, M. R.; Scambia, G.
Surgical Techniques for Diaphragmatic Resection During Cytoreduction in Advanced or Recurrent Ovarian Carcinoma A Systematic Review and Meta-analysis
2016-01-01 Bogani, G; Ditto, A; Martinelli, F; Lorusso, D; Chiappa, V; Donfrancesco, C; Di Donato, V; Indini, A; Aletti, G; Raspagliesi, F
Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment: A literature review
2021-01-01 Giudice, E; Salutari, V; Ricci, C; Nero, C; Carbone, Mv; Ghizzoni, V; Musacchio, L; Landolfo, C; Perri, Mt; Camarda, F; Scambia, G; Lorusso, D
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome)
2007-01-01 Lorusso, D; Di Stefano, A.; Carone, V.; Fagotti, A.; Pisconti, S.; Scambia, G.
Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity
2009-01-01 Lorusso, D; Mainenti, Sara; Pietragalla, Antonella; Ferrandina, Gabriella; Foco, Gilda; Masciullo, Valeria; Scambia, Giovanni
Sentinel Node Mapping Using Hysteroscopic Injection of Indocyanine Green and Laparoscopic Near-Infrared Fluorescence Imaging in Endometrial Cancer Staging
2015-01-01 Ditto, A; Martinelli, F; Bogani, G; Papadia, A; Lorusso, D; Raspagliesi, F
Editorial: Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials
2010-01-01 Lorusso, D; Mainenti, ; S., A.; Ferrandina, ; G., B.; Scambia, ; G., B.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial | 1-gen-2016 | Lorusso, D; Scambia, G; Pignata, S; Sorio, R; Amadio, G; Lepori, S; Mosconi, A; Pisano, C; Mangili, G; Maltese, G; Sabbatini, R; Artioli, G; Gamucci, T; Di Napoli, M; Capoluongo, E; Ludovini, V; Raspagliesi, F; Ferrandina, G | |
| Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial | 1-gen-2023 | Monk, Bradley J; Tewari, Krishnansu S; Dubot, Coraline; Caceres, M Valeria; Hasegawa, Kosei; Shapira-Frommer, Ronnie; Salman, Pamela; Yañez, Eduardo; Gümüş, Mahmut; Hurtado de Mendoza, Mivael Olivera; Samouëlian, Vanessa; Castonguay, Vincent; Arkhipov, Alexander; Tekin, Cumhur; Li, Kan; Martin Nguyen, Allison; Monberg, Matthew J; Colombo, Nicoletta; Lorusso, Domenica | |
| Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS) | 1-gen-2018 | Roncolato, Ft; Berton-Rigaud, D; O'Connell, R; Lanceley, A; Sehouli, J; Buizen, L; Okamoto, A; Aotani, E; Lorusso, D; Donnellan, P; Oza, A; Avall-Lundqvist, E; Berek, J; Hilpert, F; Ledermann, Ja; Kaminsky, Mc; Stockler, Mr; King, Mt; Friedlander, M. | |
| Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials | 1-gen-2019 | Daniele, G; Arenare, L; Scambia, G; Pisano, C; Sorio, R; Breda, E; De Placido, S; Savarese, A; Ferrandina, G; Raspagliesi, F; Panici, Pb; Ferro, A; Rimanti, A; Cormio, G; Lorusso, D; Cecere, Sc; Scalone, S; Marsico, Va; Cardalesi, C; Cognetti, F; Salutari, V; Attademo, L; Guizzaro, L; Schettino, C; Piccirillo, Mc; Perrone, F; Gallo, C; Pignata, S. | |
| Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study | 1-gen-2008 | Adamo, V.; Lorusso, V.; Rossello, R.; Adamo, B.; Ferraro, G.; Lorusso, D; Condemi, G.; Priolo, D.; Di Lullo, L.; Paglia, A.; Pisconti, S.; Scambia, G.; Ferrandina, G. | |
| Carboplatin-Paclitaxel Versus Cisplatin-Ifosfamide in the Treatment of Uterine Carcinosarcoma A Retrospective Cohort Study | 1-gen-2014 | Lorusso, D; Martinelli, F; Mancini, M; Sarno, I; Ditto, A; Raspagliesi, F | |
| The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study | 1-gen-2017 | Bogani, G; Matteucci, L; Tamberi, S; Arcangeli, V; Ditto, A; Maltese, G; Signorelli, M; Martinelli, F; Chiappa, V; Leone Roberti Maggiore, U; Perotto, S; Scaffa, C; Comerci, G; Stefanetti, M; Raspagliesi, F; Lorusso, D | |
| Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer | 1-gen-2002 | D'Agostino, G; Ferrandina, G; Garganese, G; Salerno, Mg; Lorusso, D; Farnetano, Mg; Mancuso, S; Scambia, G | |
| Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial | 1-gen-2014 | Pignata, S; Scambia, G; Katsaros, D; Gallo, C; Pujade-Lauraine, E; De Placido, S; Bologna, A; Weber, B; Raspagliesi, F; Panici, Pb; Cormio, G; Sorio, R; Cavazzini, Mg; Ferrandina, G; Breda, E; Murgia, V; Sacco, C; Cinieri, S; Salutari, V; Ricci, C; Pisano, C; Greggi, S; Lauria, R; Lorusso, D; Marchetti, C; Selvaggi, L; Signoriello, S; Piccirillo, Mc; Di Maio, M; Perrone, F; Martinelli, F; Multicentre Italian Trials in Ovarian cancer, (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein, (GINECO); Mario Negri Gynecologic Oncology, (MaNGO); European Network of Gynaecological Oncological Trial Groups, (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG), Investigators | |
| Emerging drugs for ovarian cancer | 1-gen-2010 | Lorusso, D; Pietragalla, Antonella; Mainenti, Sara; Di Legge, Alessia; Amadio, Giulia; Scambia, Giovanni | |
| Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer | 1-gen-2020 | Lorusso, D; Ceni, V; Muratore, M; Salutari, V; Nero, C; Pietragalla, A; Ciccarone, F; Carbone, V; Daniele, G; Scambia, G; Lorusso, D; Ceni, V; Muratore, M; Salutari, V; Nero, C; Pietragalla, A; Ciccarone, F; Carbone, V; Daniele, G; Scambia, G | |
| Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors | 1-gen-2014 | Brown, J; Friedlander, M; Backes, Fj; Harter, P; O'Connor, Dm; Rouge, Td; Lorusso, D; Maenpaa, J; Kim, Jw; Tenney, Me; Seckl, Mj | |
| Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety | 1-gen-2019 | Kristeleit, Rs; Oaknin, A; Ray-Coquard, I; Leary, A; Balmaña, J; Drew, Y; Oza, Am; Shapira-Frommer, R; Domchek, Sm; Cameron, T; Maloney, L; Goble, S; Lorusso, D; Ledermann, Ja; Mcneish, Ia. | |
| Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study | 1-gen-2007 | Ferrandina, G.; Ludovisi, M.; De Vincenzo, R.; Salutari, V.; Lorusso, D; Colangelo, M.; Prantera, T.; Valerio, M. R.; Scambia, G. | |
| Surgical Techniques for Diaphragmatic Resection During Cytoreduction in Advanced or Recurrent Ovarian Carcinoma A Systematic Review and Meta-analysis | 1-gen-2016 | Bogani, G; Ditto, A; Martinelli, F; Lorusso, D; Chiappa, V; Donfrancesco, C; Di Donato, V; Indini, A; Aletti, G; Raspagliesi, F | |
| Gut microbiota and its influence on ovarian cancer carcinogenesis, anticancer therapy and surgical treatment: A literature review | 1-gen-2021 | Giudice, E; Salutari, V; Ricci, C; Nero, C; Carbone, Mv; Ghizzoni, V; Musacchio, L; Landolfo, C; Perri, Mt; Camarda, F; Scambia, G; Lorusso, D | |
| Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia ('hand-foot' syndrome) | 1-gen-2007 | Lorusso, D; Di Stefano, A.; Carone, V.; Fagotti, A.; Pisconti, S.; Scambia, G. | |
| Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity | 1-gen-2009 | Lorusso, D; Mainenti, Sara; Pietragalla, Antonella; Ferrandina, Gabriella; Foco, Gilda; Masciullo, Valeria; Scambia, Giovanni | |
| Sentinel Node Mapping Using Hysteroscopic Injection of Indocyanine Green and Laparoscopic Near-Infrared Fluorescence Imaging in Endometrial Cancer Staging | 1-gen-2015 | Ditto, A; Martinelli, F; Bogani, G; Papadia, A; Lorusso, D; Raspagliesi, F | |
| Editorial: Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials | 1-gen-2010 | Lorusso, D; Mainenti, ; S., A.; Ferrandina, ; G., B.; Scambia, ; G., B. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26879
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269083
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS227
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE182
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19160
- ita408
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24626
- reserved1362
- open891